See more : Shearwater Group plc (SWG.L) Income Statement Analysis – Financial Results
Complete financial analysis of Bonzun AB (publ) (BONZUN.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bonzun AB (publ), a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Aridis Pharmaceuticals, Inc. (ARDS) Income Statement Analysis – Financial Results
- Home Plate Acquisition Corporation (HPLTW) Income Statement Analysis – Financial Results
- Golden Mile Resources Limited (G88.AX) Income Statement Analysis – Financial Results
- Quantum BioPharma Ltd (QNTM) Income Statement Analysis – Financial Results
- Skanska AB (publ) (SKSBF) Income Statement Analysis – Financial Results
Bonzun AB (publ) (BONZUN.ST)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.bonzun.com
About Bonzun AB (publ)
Bonzun AB (publ) operates as a healthcare company that provides Internet-based health services in Sweden. The company offers solutions for stress-related disorders. It also provides support services to the therapists who work with stress, cardiovascular disease, anxiety, relationship problems, etc. The company was formerly known as Papilly AB (publ) and changed its name to Bonzun AB (publ). Bonzun AB (publ) is based in Stockholm, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.74M | 1.09M | 359.48K | 554.88K | 1.32M | 1.09M | 905.75K | 16.82K | 61.36K | 0.00 | 50.01K |
| Cost of Revenue | 27.99M | 10.00K | 9.65M | 9.06M | 13.39M | 12.16M | 20.14M | 8.69M | 7.16M | 0.00 | 0.00 |
| Gross Profit | -25.25M | 1.08M | -9.29M | -8.50M | -12.07M | -11.07M | -19.24M | -8.67M | -7.10M | 0.00 | 50.01K |
| Gross Profit Ratio | -923.07% | 99.08% | -2,583.41% | -1,531.90% | -914.98% | -1,018.04% | -2,123.87% | -51,552.93% | -11,566.80% | 0.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 7.84M | 5.05M | 4.90M | 6.85M | 4.87M | 11.50M | 0.00 | 4.91M | 4.82M | 5.77M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.00 | 7.84M | 5.05M | 4.90M | 6.85M | 4.87M | 11.50M | 0.00 | 4.91M | 4.82M | 5.77M |
| Other Expenses | 0.00 | 26.88M | 4.49M | 4.15M | 6.54M | 7.29M | 8.65M | 8.69M | 2.44M | 505.92K | 2.20K |
| Operating Expenses | 5.00 | 34.73M | 9.53M | 9.06M | 13.39M | 12.16M | 20.15M | 8.69M | 7.36M | 5.32M | 5.77M |
| Cost & Expenses | 27.99M | 34.74M | 9.53M | 9.06M | 13.39M | 12.16M | 20.15M | 8.69M | 7.36M | 5.32M | 5.77M |
| Interest Income | 10.67K | 0.00 | 314.00K | 0.00 | 0.00 | 0.00 | 0.00 | 29.00 | 0.00 | 973.00 | 1.00K |
| Interest Expense | 6.53M | 2.40M | 716.74K | 457.88K | 649.46K | 497.01K | 1.33M | 1.76M | 27.39K | 4.33K | 380.82K |
| Depreciation & Amortization | 6.23M | 21.96M | 2.48M | 23.90K | 23.90K | 3.34M | 3.14M | 1.56M | 577.24K | 2.20K | 2.20K |
| EBITDA | -28.58M | -14.15M | -6.38M | -8.95M | -12.04M | -7.73M | -16.09M | -7.11M | -6.72M | -5.32M | -6.11M |
| EBITDA Ratio | -1,044.77% | -1,299.54% | -1,773.65% | -906.57% | -660.79% | -710.83% | -1,777.14% | -42,285.89% | -10,947.92% | 0.00% | -11,432.63% |
| Operating Income | -25.25M | -33.65M | -9.17M | -8.50M | -12.07M | -11.07M | -19.24M | -8.67M | -7.29M | -5.32M | -5.76M |
| Operating Income Ratio | -923.07% | -3,089.72% | -2,551.71% | -1,531.90% | -914.98% | -1,018.04% | -2,124.65% | -51,552.93% | -11,888.67% | 0.00% | -11,527.03% |
| Total Other Income/Expenses | -16.09M | -4.86M | -402.74K | -934.95K | -649.46K | -497.01K | -1.33M | -1.76M | -27.39K | -3.36K | 93.00 |
| Income Before Tax | -41.34M | -38.51M | -9.58M | -9.44M | -12.72M | -11.57M | -20.57M | -10.43M | -7.32M | -5.33M | -6.14M |
| Income Before Tax Ratio | -1,511.05% | -3,536.36% | -2,663.75% | -1,700.39% | -964.22% | -1,063.74% | -2,271.55% | -62,032.29% | -11,933.31% | 0.00% | -12,288.60% |
| Income Tax Expense | -55.23M | 4.86M | 716.74K | 934.95K | 649.46K | 497.01K | 1.33M | 1.76M | 27.39K | 3.36K | 425.83K |
| Net Income | 13.88M | -43.38M | -10.29M | -10.37M | -13.37M | -11.57M | -20.57M | -10.43M | -7.32M | -5.33M | -6.14M |
| Net Income Ratio | 507.47% | -3,983.01% | -2,863.13% | -1,868.89% | -1,013.46% | -1,063.74% | -2,271.55% | -62,032.29% | -11,933.31% | 0.00% | -12,288.60% |
| EPS | 0.11 | -1.26 | -0.02 | -1.74 | -3.40 | -3.36 | -53.86 | -36.37 | -29.45 | -24.25 | -37.03 |
| EPS Diluted | 0.11 | -1.26 | -0.02 | -1.74 | -3.40 | -3.36 | -53.19 | -35.92 | -29.08 | -24.25 | -27.98 |
| Weighted Avg Shares Out | 124.46M | 34.39M | 575.76M | 5.96M | 3.94M | 3.44M | 382.01K | 286.83K | 248.67K | 219.60K | 165.95K |
| Weighted Avg Shares Out (Dil) | 124.46M | 34.39M | 575.76M | 5.96M | 3.94M | 3.44M | 386.82K | 290.44K | 251.80K | 219.60K | 219.60K |
Source: https://incomestatements.info
Category: Stock Reports